Skip to main content
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.590
+0.020 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
4.640
+0.050 (1.09%)
After-hours: Mar 9, 2026, 5:41 PM EDT

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $6.31M in the twelve months ending September 30, 2025, down -36.36% year-over-year. In the year 2024, Taysha Gene Therapies had annual revenue of $8.33M, down -46.07%.

Revenue (ttm)
$6.31M
Revenue Growth
-36.36%
P/S Ratio
199.25
Revenue / Employee
$86,438
Employees
73
Market Cap
1.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Immatics 56.67M
EyePoint 31.37M
Septerna 22.05M
Zenas BioPharma 15.00M
Precigen 6.31M
DBV Technologies 5.50M
AtaiBeckley 4.09M
Revenue Rankings

TSHA News

More News